Napredna pretraga

Pregled bibliografske jedinice broj: 806945

Chronic obstructive pulmonary disease and comorbidities


Sokolović, Irena; Knežević, Jelena; Popović-Grle, Sanja; Vukić Dugac, Andrea; Bubanović, Gordana; Janković Makek, Mateja; Hećimović, Ana; Redžepi, Gzim; Samaržija, Miroslav; Jakopovic, Marko
Chronic obstructive pulmonary disease and comorbidities // 25th Annual Congress of the European Respiratory Society (ERS 2015) ; u: European Respiratory Journal 46 (2015)(S 59)
Amsterdam, Nizozemska, 2015. str. PA1123 P-PA1123 P (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Chronic obstructive pulmonary disease and comorbidities

Autori
Sokolović, Irena ; Knežević, Jelena ; Popović-Grle, Sanja ; Vukić Dugac, Andrea ; Bubanović, Gordana ; Janković Makek, Mateja ; Hećimović, Ana ; Redžepi, Gzim ; Samaržija, Miroslav ; Jakopovic, Marko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
25th Annual Congress of the European Respiratory Society (ERS 2015) ; u: European Respiratory Journal 46 (2015)(S 59) / - , 2015, PA1123 P-PA1123 P

Skup
Annual Congress of the European Respiratory Society (25 ; 2015)

Mjesto i datum
Amsterdam, Nizozemska, 26-30, 09, 2015

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Chronic obstructive lung diseases

Sažetak
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Although it is well known that comorbidities are highly prevalent in patients with COPD, they are not considered for treatment effect analysis. To observe frequency of comorbidities in patients with COPD and compare its distribution in 4 GOLD groups. Observational cross sectional study was designed to identify comorbidities related with categorized disease groups. Patients with COPD treated at University Hospital Centre were included. Severity of COPD was estimated and number of comorbidities was counted. Comorbidity was defined as the presence of disorder in addition to COPD irrespective of their relation to COPD. We enrolled 460 COPD patients (68, 5% males ; average age at diagnosis 61, 3 years. Majority of patients were in GOLD group A (41%) and B (29%), followed by group D (25%) and C (5%). Comorbidities were present in 90% of patients, with 31% of patients with 1 comorbidity, 31% with 2 comorbidities and 28% with 3 or more (mean of 1.9). There was no significant difference in number of comorbidities among GOLD groups (P=0.81). Most common comorbidities were arterial hypertension (47%), lung neoplasm (40%) and cardiovascular diseases (23%). We showed that COPD is rarely diagnosed as an isolated condition, since different comorbidities were present in 90% of patients. Hypertension, lung neoplasms and cardiovascular diseases were revealed as the most common ones. High proportion of lung cancer can be attributed to searching for COPD in lung cancer patients. A multidimensional COPD diagnosis approach should be taken into account when classifying COPD patients into GOLD groups.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

Napomena
DOI: 10.1183/13993003.congress-2015.PA1123



POVEZANOST RADA


Ustanove
Institut "Ruđer Bošković", Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE